Evidence map›Paper›PMID 34348893›Full record

ArticleScience advances2021

GRB2 enforces homology-directed repair initiation by MRE11.

Zu Ye, Shengfeng Xu, Yin Shi, Albino Bacolla, Aleem Syed, Davide Moiani, Chi-Lin Tsai, Qiang Shen, Guang Peng, Paul G Leonard and 4 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 34 citations in OpenAlex.

  1. Taming Mre11-Rad50 at Telomeres: Convergent Strategies for Chromosome-End Protection Across Evolution.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Zu YeDepartments of Molecular and Cellular Oncology and Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID http://orcid.org/0000-0003-0846-7548
Shengfeng XuDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID http://orcid.org/0000-0002-5774-7549
Yin ShiDepartment of Biochemistry, Zhejiang University School of Medicine, Hangzhou 310058, China.ORCID http://orcid.org/0000-0003-3858-8500
Albino BacollaDepartments of Molecular and Cellular Oncology and Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID http://orcid.org/0000-0003-0206-8423
Aleem SyedDepartments of Molecular and Cellular Oncology and Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Davide MoianiDepartments of Molecular and Cellular Oncology and Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID http://orcid.org/0000-0003-0715-8508
Chi-Lin TsaiDepartments of Molecular and Cellular Oncology and Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID http://orcid.org/0000-0002-0365-2405
Qiang ShenLouisiana State University Health Sciences Center, New Orleans, LA 70112, USA.ORCID http://orcid.org/0000-0002-1491-5434
Guang PengDepartment of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID http://orcid.org/0000-0002-4392-1497
Paul G LeonardInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, TX 77054, USA.ORCID http://orcid.org/0000-0003-2661-5532
Darin E JonesDepartment of Pharmaceutical Sciences, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205, USA.ORCID http://orcid.org/0000-0003-1581-3453
Bin WangDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID http://orcid.org/0000-0003-3352-6992
John A TainerDepartments of Molecular and Cellular Oncology and Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. zahmed@mdanderson.org jtainer@mdanderson.org.ORCID http://orcid.org/0000-0003-1659-2429
Zamal AhmedDepartments of Molecular and Cellular Oncology and Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. zahmed@mdanderson.org jtainer@mdanderson.org.ORCID http://orcid.org/0000-0003-3400-6577
The University of Texas MD Anderson Cancer Center · USLouisiana State University Health Sciences Center New Orleans · USUniversity of Arkansas for Medical Sciences · US

Funding

Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI John A. Tainer · 2001 to 2026
$89.6M
Mesoscale and Nanoscale Technologies Integrated by Structures for DNA Repair Complexes (MANTIS-DRC)R35CA220430 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI John A. Tainer · 2018 to 2026
$7.6M
PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISMR01CA200231 · NCI · WASHINGTON UNIVERSITY · PI AHMED, ZAMAL, JONES, DARIN E. · 2016 to 2020
$1.7M
Orbitrap Elite High-Resolution Mass Spectrometer for Proteomics and MetabolomicsS10OD012304 · OD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HAWKE, DAVID H · 2013 to 2013
$877k
NCI NIH HHS P01 CA092584NCI NIH HHS R01 CA200231NCI NIH HHS R35 CA220430NIH HHS S10 OD012304
6 · The paper itself

Abstract

DNA double-strand break (DSB) repair is initiated by MRE11 nuclease for both homology-directed repair (HDR) and alternative end joining (Alt-EJ). Here, we found that GRB2, crucial to timely proliferative RAS/MAPK pathway activation, unexpectedly forms a biophysically validated GRB2-MRE11 (GM) complex for efficient HDR initiation. GRB2-SH2 domain targets the GM complex to phosphorylated H2AX at DSBs. GRB2 K109 ubiquitination by E3 ubiquitin ligase RBBP6 releases MRE11 promoting HDR. RBBP6 depletion results in prolonged GM complex and HDR defects. GRB2 knockout increased MRE11-XRCC1 complex and Alt-EJ. Reconstitution with separation-of-function GRB2 mutant caused HDR deficiency and synthetic lethality with PARP inhibitor. Cell and cancer genome analyses suggest biomarkers of low GRB2 for noncanonical HDR deficiency and high MRE11 and GRB2 expression for worse survival in HDR-proficient patients. These findings establish GRB2's role in binding, targeting, and releasing MRE11 to promote efficient HDR over Alt-EJ DSB repair, with implications for genome stability and cancer biology.

Identifiers

PMID34348893
PMCPMC8336959
OpenAlexW3190653485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.